Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
Completed · Not applicable
Conditions studied: Asthma, Pneumonia, Bronchiolitis
In brief
This study's objective is to identify and test pragmatic and sustainable strategies for implementing a multi-condition clinical pathway intervention for children hospitalized with asthma, pneumonia, or bronchiolitis in community hospitals. The hypothesis is that the multi-condition pathway intervention will be associated with significantly greater increases in clinicians' adoption of evidence-based practices compared to control. The study is a pragmatic, cluster-randomized trial in US community hospitals. The primary outcome will be adoption of evidence-based practices over a sustained period of 2 years. Secondary outcomes include length of hospital stay, intensive care unit transfer, and hospital readmission/emergency department revisit.
Key facts
- Study ID
- NCT05206695
- Run by
- University of California, San Francisco
- People needed
- 11760
- Starts
- 2022-05-13
- Expected to finish
- 2025-10-21
- Last updated by the study team
- 2026-04-20
Who can join
Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Primary diagnosis of asthma AND age >2 to <18 years-old at time of admission to the hospital OR
- Primary diagnosis of pneumonia AND age >2 months and <18 years at time of admission to the hospital OR
- Primary diagnosis of bronchiolitis AND age <2 years at time of admission to the hospital
You may not qualify if…
- Diagnosis of SARS-CoV-2
- Transfer in from another inpatient facility
- Pre-existing chronic illnesses (e.g., lung disease, cardiovascular disease, neurologic disorders)
Where it is running
- University of California, San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.